Clinical Development Reports
Oncology Clinical Trials (PH180)
Benchmark oncology clinical trials’ key metrics, including cost-drivers, duration, staffing and budgets.
Optimizing Clinical Pharmacology Programs (PH173)
Manage critical Phase I cost-drivers and prevent expensive delays to move projects through early-stage trials.
Companion Diagnostics and Biomarker Development (PH169)
Harness companion diagnostic metrics to set strategy, improve partner selection and build a program of targeted therapy development.
Phase IV Clinical Trials (PH157)
Improve Phase IV strategy and execution with strong leadership and benchmarks for budgets, staffing, trial timelines and more.
Clinical Operations (PH152)
Emerging Markets Clinical Trials: Africa (PH147)
Explore the next frontier of emerging markets to build a clinical foundation that generates decades of benefits for developers and patients.
Emerging Markets Clinical Trials: Latin America (PH146)
Boost trials with Latin America’s untapped clinical promise, including patient availability, established infrastructure, and convenient communication.
Emerging Markets Clinical Trials: Eastern Europe (PH145)
Make sense of Europe’s emerging markets to accelerate clinical development and save money while addressing region-specific cultural
challenges in clinical trials.
Emerging Markets Clinical Trials: Asia (PH144)
Navigate the maze of emerging Asian markets to improve patient access and retention while sidestepping clinical teams' common mistakes.
Emerging Markets Clinical Trials: BRIC Countries (PH143)
Confidently tap BRIC's potential to deliver patients and lower costs while avoiding the pitfalls common to these new markets.
Clinical Trial Patient Recruitment (PH140)
Chart a comprehensive recruiting and retention strategy with specific tools, processes and resource benchmarks.
Strategic Clinical Outsourcing (PH125)
Benchmark unit hour costs, project budgets and trial timelines to make the most of your clinical outsourcing strategy.
Managing Clinical Investigator Compensation (PH126)
Build a transparent compensation system based on fair-market value to attract investigators while avoiding compliance pitfalls.








